ARLUVOIZ Trademark

Prosecution Summary

Trademark Summary
The mark ARLUVOIZ is a standard character word mark covering pharmaceutical preparations in International Class 005 for the treatment and prevention of various diseases and disorders, including bone, cardiovascular, central nervous system, oncological, and others, as well as inhalers, antibiotics, antivirals, and human vaccines; it also spans U.S. classes 006, 018, 044, 046, 051, and 052. The mark is owned by Merck Sharp & Dohme B.V., a Netherlands-based BESLOTEN VENNOOTSCHAP (B.V.). It is currently registered on the Principal Register, with registration number 8134320 issued on February 10, 2026.

Recent Activity
Filed on June 27, 2025 with priority claimed from a Benelux registration (No. 1527156), the application faced a suspension i

Trademark Facts

Goods & Services

Pharmaceutical preparations for the treatment and prevention of bone, cardiovascular, central nervous system, dermatological, endocrine, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, and urological diseases and disorders; Pharmaceutical preparations for the treatment and prevention of autoimmune diseases, asthma, cancer and tumors, chronic cough, diabetes, hypertension, insomnia, intestinal infections, skin disorders, and urinary incontinence; Inhalers filled with pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Anti-infectives; Anti-inflammatories; Antiparasitics; Antivirals; Human vaccine preparations

Related

• All trademarks from Merck Sharp & Dohme B.V.
• More marks in Class 005
• Search for similar marks to ARLUVOIZ
• Run a clearance check
• Free USPTO trademark search